|
DESCRIPTION OF BUSINESS
|
12 Months Ended |
|---|---|
|
Dec. 31, 2012
|
|
| DESCRIPTION OF BUSINESS | |
| DESCRIPTION OF BUSINESS |
NOTE 1 – DESCRIPTION OF BUSINESS
Health Enhancement Products, Inc. and Subsidiaries’ (the Company) business model is to derive future income from licensing and selling natural bioactive ingredients derived from their proprietary algae cultures to animal and dietary supplement and medical food manufacturers. Currently, the Company's focus is on research and identification of its bioactive ingredients and is not currently selling its product commercially. Its wholly owned subsidiary, HEPI Pharmaceuticals, Inc. intends to develop potential pharmaceuticals applications of ProAlgaZyme® (PAZ). |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The entire disclosure for the nature of an entity's business, the major products or services it sells or provides and its principal markets, including the locations of those markets. If the entity operates in more than one business, the disclosure also indicates the relative importance of its operations in each business and the basis for the determination (for example, assets, revenues, or earnings). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|